Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion

Full text
Author(s):
Ribeiro, Thiago B. [1] ; Duarte, Adriana S. S. [1] ; Longhini, Ana Leda F. [2, 1] ; Pradella, Fernando [2] ; Farias, Alessandro S. [2] ; Luzo, Angela C. M. [1] ; Oliveira, Alexandre L. R. [3] ; Olalla Saad, Sara Teresinha [1]
Total Authors: 8
Affiliation:
[1] Univ Estadual Campinas, Inst Nacl Ciencia & Tecnol Sangue, Hemoctr Unicamp, Hematol & Hemotherapy Ctr, Sao Paulo - Brazil
[2] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Neuroimmunomodulat Grp, Campinas, SP - Brazil
[3] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: SCIENTIFIC REPORTS; v. 5, NOV 9 2015.
Web of Science Citations: 21
Abstract

The present study investigates the effects of xenotransplantation of Adipose Tissue Mesenchymal Stem Cells (AT-MSCs) in animals after ventral root avulsion. AT-MSC has similar characteristics to bone marrow mesenchymal stem cells (BM-MSCs), such as immunomodulatory properties and expression of neurotrophic factors. In this study, Lewis rats were submitted to surgery for unilateral avulsion of the lumbar ventral roots and received 5 x 10(5) AT-MSCs via the lateral funiculus. Two weeks after cell administration, the animals were sacrificed and the moto neurons, T lymphocytes and cell defense nervous system were analyzed. An increased neuronal survival and partial preservation of synaptophysin-positive nerve terminals, related to GDNF and BDNF expression of AT-MSCs, and reduction of pro-inflammatory reaction were observed. In conclusion, AT-MSCs prevent second phase neuronal injury, since they suppressed lymphocyte, astroglia and microglia effects, which finally contributed to rat motor-neuron survival and synaptic stability of the lesioned motorneuron. Moreover, the survival of the injected AT-MSCs lasted for at least 14 days. These results indicate that neuronal survival after lesion, followed by mesenchymal stem cell (MSC) administration, might occur through cytokine release and immunomodulation, thus suggesting that AT-MSCs are promising cells for the therapy of neuronal lesions. (AU)

FAPESP's process: 08/57895-1 - National Institute of Blood Technology and Science
Grantee:Sara Teresinha Olalla Saad
Support type: Research Projects - Thematic Grants